{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:39:17Z","timestamp":1793407157796,"version":"4.5.0"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2024-00441331"],"award-info":[{"award-number":["RS-2024-00441331"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Biomed Sci"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Parkinson\u2019s disease (PD) is the second most common neurodegenerative disorder, categorized by the loss of dopaminergic neurons in the brain\u2019s Substantia Nigra pars compacta (SNpc) due to \u03b1-synuclein (\u03b1-syn) aggregation, leading to reduced dopamine levels in the striatum. This research study evaluates the neuroprotective potential of the novel peptide osmotin-derived 9-amino-acid (Os_9aa, C-T-Q-G-P-C-G-P-T) against \u03b1-syn (neuron-specific enolase promoter human alpha-synuclein (NSE-h\u03b1Syn)) and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Human neuroblastoma SH-SY5Y cells were employed as an in vitro model, while NSE-h\u03b1Syn (\u03b1-synuclein) transgenic mice and MPTP-treated mice were used as in vivo models of PD. MPTP was administered intraperitoneally (30\u00a0mg\/kg) once daily for five consecutive days. Mice were immunized with Os_9aa (15\u00a0mg\/kg, i.p., twice weekly for five weeks), followed by behavioral assessments including open field test, wire hang test, pole test, and rotarod test, and biochemical analysis using the Triplex Assay, western blotting, and confocal microscopy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Our study demonstrated that the novel peptide Os_9aa enhanced cell viability, reduced cytotoxicity, and apoptosis in SH-SY5Y neuroblastoma cells. Os_9aa attenuated synucleinopathy-related pathology in NSE-h\u03b1Syn transgenic mice and MPTP-induced PD mouse models. Current findings also highlighted the therapeutic potential of Os_9aa in mitigating behavioral deficits observed in NSE-h\u03b1Syn and MPTP mouse models of PD. Furthermore, Os_9aa administration effectively restored key dopaminergic markers, including tyrosine hydroxylase (TH), vesicular monoamine transporter 2 (VMAT2), and dopamine transporter (DAT). Additionally, it reduced neuroinflammation by decreasing the activation of glial cells\u2014ionized calcium-binding adaptor molecule 1 (Iba-1) and glial fibrillary acidic protein (GFAP), as well as pro-inflammatory cytokines, such as phosphorylated nuclear factor-\u03baB (p-NF-\u043aB), tumor necrosis factor-\u03b1 (TNF-\u03b1), and interleukin-1\u03b2 (IL-1\u03b2), in the striatum and SNpc regions. Furthermore, Os_9aa mitigated oxidative stress (OS) by upregulating the expression of nuclear factor erythroid-related factor 2 (Nrf-2) and heme oxygenase 1 (HO-1), and improved cognitive performance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Collectively, these findings highlight the neuroprotective potential of the Os_9aa, which counteracts \u03b1-synuclein\u2013 and MPTP-induced neurotoxicity by reducing oxidative stress, glial activation, and neuroinflammation. This multifaceted protection preserves neuronal integrity in both the NSE-h\u03b1Syn transgenic and MPTP-induced PD mouse models, underscoring Os_9aa as a promising therapeutic candidate for modifying PD pathogenesis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12929-026-01215-4","type":"journal-article","created":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T04:47:52Z","timestamp":1769402872000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Osmotin-derived 9-amino-acid peptide alleviates \u03b1-synuclein and MPTP-induced glial cell activation mediated neuroinflammation, protecting dopaminergic neurons in Parkinson\u2019s disease mice brain"],"prefix":"10.1186","volume":"33","author":[{"given":"Kyonghwan","family":"Choe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Tahir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Hwa","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Young","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riaz","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Ju","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myeong Ok","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,26]]},"reference":[{"issue":"4","key":"1215_CR1","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.cell.2022.12.032","volume":"186","author":"DM Wilson","year":"2023","unstructured":"Wilson DM, et al. Hallmarks of neurodegenerative diseases. Cell. 2023;186(4):693\u2013714.","journal-title":"Cell"},{"key":"1215_CR2","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.bbi.2022.01.007","volume":"101","author":"AA Karikari","year":"2022","unstructured":"Karikari AA, et al. Neurodegeneration by \u03b1-synuclein-specific T cells in AAV-A53T-\u03b1-synuclein Parkinson\u2019s disease mice. Brain Behav Immun. 2022;101:194\u2013210.","journal-title":"Brain Behav Immun"},{"key":"1215_CR3","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/jnc.13385","volume":"139","author":"A Migdalska-Richards","year":"2016","unstructured":"Migdalska-Richards A, Schapira AH. The relationship between glucocerebrosidase mutations and Parkinson disease. J Neurochem. 2016;139:77\u201390.","journal-title":"J Neurochem"},{"key":"1215_CR4","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s12264-017-0183-5","volume":"33","author":"S Lotankar","year":"2017","unstructured":"Lotankar S, Prabhavalkar KS, Bhatt LK. Biomarkers for Parkinson\u2019s disease: recent advancement. Neurosci Bull. 2017;33:585\u201397.","journal-title":"Neurosci Bull"},{"key":"1215_CR5","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.neuroscience.2013.01.007","volume":"236","author":"H Gao","year":"2013","unstructured":"Gao H, et al. Attenuation of MPTP\/MPP+ toxicity in vivo and in vitro by an 18-mer peptide derived from prosaposin. Neuroscience. 2013;236:373\u201393.","journal-title":"Neuroscience"},{"issue":"7","key":"1215_CR6","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.amjmed.2019.03.001","volume":"132","author":"MT Hayes","year":"2019","unstructured":"Hayes MT. Parkinson\u2019s disease and parkinsonism. Am J Med. 2019;132(7):802\u20137.","journal-title":"Am J Med"},{"issue":"5","key":"1215_CR7","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1056\/NEJMoa2202867","volume":"387","author":"G Pagano","year":"2022","unstructured":"Pagano G, et al. Trial of prasinezumab in early-stage Parkinson\u2019s disease. New Engl J Med. 2022;387(5):421\u201332.","journal-title":"New Engl J Med"},{"issue":"5","key":"1215_CR8","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1056\/NEJMoa2203395","volume":"387","author":"AE Lang","year":"2022","unstructured":"Lang AE, et al. Trial of cinpanemab in early Parkinson\u2019s disease. New Engl J Med. 2022;387(5):408\u201320.","journal-title":"New Engl J Med"},{"issue":"18","key":"1215_CR9","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1212\/WNL.0b013e3182904faa","volume":"80","author":"RT Bartus","year":"2013","unstructured":"Bartus RT, et al. Safety\/feasibility of targeting the substantia nigra with AAV2-neurturin in Parkinson patients. Neurology. 2013;80(18):1698\u2013701.","journal-title":"Neurology"},{"issue":"10","key":"1215_CR10","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1001\/jama.2021.10207","volume":"326","author":"MA Schwarzschild","year":"2021","unstructured":"Schwarzschild MA, et al. Effect of urate-elevating inosine on early Parkinson disease progression: the sure-pd3 randomized clinical trial. JAMA. 2021;326(10):926\u201339.","journal-title":"JAMA"},{"issue":"5","key":"1215_CR11","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1001\/jamaneurol.2014.131","volume":"71","author":"MF Beal","year":"2014","unstructured":"Beal MF, et al. A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit. JAMA Neurol. 2014;71(5):543\u201352.","journal-title":"JAMA Neurol"},{"issue":"1","key":"1215_CR12","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s12967-023-04012-x","volume":"21","author":"B Xiao","year":"2023","unstructured":"Xiao B, Tan EK. Immunotherapy trials in Parkinson\u2019s disease: challenges. J Transl Med. 2023;21(1):178.","journal-title":"J Transl Med"},{"issue":"4","key":"1215_CR13","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1007\/s13311-020-00964-w","volume":"17","author":"AY Hung","year":"2020","unstructured":"Hung AY, Schwarzschild MA. Approaches to disease modification for Parkinson\u2019s Disease: clinical trials and lessons learned. Neurotherapeutics. 2020;17(4):1393\u2013405.","journal-title":"Neurotherapeutics"},{"key":"1215_CR14","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1007\/s11427-020-1756-9","volume":"63","author":"R Wang","year":"2020","unstructured":"Wang R, et al. \u03b1-Synuclein aggregation and transmission in Parkinson\u2019s disease: a link to mitochondria and lysosome. Sci China Life Sci. 2020;63:1850\u20139.","journal-title":"Sci China Life Sci"},{"key":"1215_CR15","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jchemneu.2018.04.005","volume":"91","author":"B Bhaduri","year":"2018","unstructured":"Bhaduri B, Abhilash P, Alladi PA. Baseline striatal and nigral interneuronal protein levels in two distinct mice strains differ in accordance with their MPTP susceptibility. J Chem Neuroanat. 2018;91:46\u201354.","journal-title":"J Chem Neuroanat"},{"issue":"3","key":"1215_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05672-9","volume":"14","author":"P Calabresi","year":"2023","unstructured":"Calabresi P, et al. Alpha-synuclein in Parkinson\u2019s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction. Cell Death Dis. 2023;14(3):176.","journal-title":"Cell Death Dis"},{"issue":"13","key":"1215_CR17","doi-asserted-by":"publisher","first-page":"8968","DOI":"10.1073\/pnas.132197599","volume":"99","author":"MK Lee","year":"2002","unstructured":"Lee MK, et al. Human \u03b1-synuclein-harboring familial Parkinson\u2019s disease-linked Ala-53\u2192 Thr mutation causes neurodegenerative disease with \u03b1-synuclein aggregation in transgenic mice. Proc Natl Acad Sci USA. 2002;99(13):8968\u201373.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"1215_CR18","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13522","volume":"20","author":"HY Tu","year":"2021","unstructured":"Tu HY, et al. \u03b1\u2010synuclein suppresses microglial autophagy and promotes neurodegeneration in a mouse model of Parkinson\u2019s disease. Aging Cell. 2021;20(12):e13522.","journal-title":"Aging Cell"},{"issue":"3","key":"1215_CR19","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.3390\/ijms24032477","volume":"24","author":"JS Deyell","year":"2023","unstructured":"Deyell JS, et al. The Interplay between \u03b1-synuclein and microglia in \u03b1-synucleinopathies. Int J Mol Sci. 2023;24(3):2477.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"1215_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10092278","volume":"10","author":"VV Goloborshcheva","year":"2022","unstructured":"Goloborshcheva VV, et al. Synuclein proteins in MPTP-induced death of substantia nigra pars compacta dopaminergic neurons. Biomedicines. 2022;10(9):2278.","journal-title":"Biomedicines"},{"issue":"1","key":"1215_CR21","volume":"2013","author":"A Shastri","year":"2013","unstructured":"Shastri A, Bonifati DM, Kishore U. Innate immunity and neuroinflammation. Mediators Inflamm. 2013;2013(1):342931.","journal-title":"Mediators Inflamm"},{"issue":"6","key":"1215_CR22","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.4049\/jimmunol.1400716","volume":"193","author":"A Katsumoto","year":"2014","unstructured":"Katsumoto A, et al. Ontogeny and functions of central nervous system macrophages. J Immunol. 2014;193(6):2615\u201321.","journal-title":"J Immunol"},{"key":"1215_CR23","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jchemneu.2016.06.001","volume":"83","author":"B Butler","year":"2017","unstructured":"Butler B, Sambo D, Khoshbouei H. Alpha-synuclein modulates dopamine neurotransmission. J Chem Neuroanat. 2017;83:41\u20139.","journal-title":"J Chem Neuroanat"},{"key":"1215_CR24","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.neuropharm.2013.05.025","volume":"73","author":"S Sathiya","year":"2013","unstructured":"Sathiya S, et al. Telmisartan attenuates MPTP induced dopaminergic degeneration and motor dysfunction through regulation of \u03b1-synuclein and neurotrophic factors (BDNF and GDNF) expression in C57BL\/6J mice. Neuropharmacology. 2013;73:98\u2013110.","journal-title":"Neuropharmacology"},{"issue":"1","key":"1215_CR25","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.neuroscience.2010.01.048","volume":"167","author":"G Xu","year":"2010","unstructured":"Xu G, et al. Catalpol attenuates MPTP induced neuronal degeneration of nigral-striatal dopaminergic pathway in mice through elevating glial cell derived neurotrophic factor in striatum. Neuroscience. 2010;167(1):174\u201384.","journal-title":"Neuroscience"},{"key":"1215_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2020.105028","volume":"144","author":"T-I Kam","year":"2020","unstructured":"Kam T-I, et al. Microglia and astrocyte dysfunction in parkinson\u2019s disease. Neurobiol Dis. 2020;144:105028.","journal-title":"Neurobiol Dis"},{"issue":"10","key":"1215_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0164094","volume":"11","author":"RJ Smeyne","year":"2016","unstructured":"Smeyne RJ, et al. Assessment of the effects of MPTP and paraquat on dopaminergic neurons and microglia in the substantia nigra pars compacta of C57BL\/6 mice. PLoS ONE. 2016;11(10):e0164094.","journal-title":"PLoS ONE"},{"issue":"6","key":"1215_CR28","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a001651","volume":"1","author":"T Lawrence","year":"2009","unstructured":"Lawrence T. The nuclear factor NF-\u03baB pathway in inflammation. Cold Spring Harb Perspect Biol. 2009;1(6):a001651.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"7","key":"1215_CR29","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.4103\/1673-5374.300980","volume":"16","author":"J Dorszewska","year":"2021","unstructured":"Dorszewska J, et al. Oxidative stress factors in Parkinson\u2019s disease. Neural Regen Res. 2021;16(7):1383\u201391.","journal-title":"Neural Regen Res"},{"key":"1215_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2024.1453038","volume":"18","author":"M Tahir","year":"2024","unstructured":"Tahir M, et al. Multifaceted neuroprotective approach of Trolox in Alzheimer\u2019s disease mouse model: targeting A\u03b2 pathology, neuroinflammation, oxidative stress, and synaptic dysfunction. Front Cell Neurosci. 2024;18:1453038.","journal-title":"Front Cell Neurosci"},{"issue":"12","key":"1215_CR31","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1038\/s12276-022-00895-w","volume":"54","author":"T-K Kim","year":"2022","unstructured":"Kim T-K, et al. Inflammation promotes synucleinopathy propagation. Exp Mol Med. 2022;54(12):2148\u201361.","journal-title":"Exp Mol Med"},{"issue":"1","key":"1215_CR32","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.foodres.2012.08.023","volume":"49","author":"R He","year":"2012","unstructured":"He R, et al. Antioxidant activities of rapeseed peptides produced by solid state fermentation. Food Res Int. 2012;49(1):432\u20138.","journal-title":"Food Res Int"},{"issue":"2","key":"1215_CR33","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s00011-018-1208-x","volume":"68","author":"M Dadar","year":"2019","unstructured":"Dadar M, et al. Antiinflammatory peptides: current knowledge and promising prospects. Inflamm Res. 2019;68(2):125\u201345.","journal-title":"Inflamm Res"},{"issue":"8","key":"1215_CR34","doi-asserted-by":"publisher","first-page":"641","DOI":"10.2174\/138920371408131227155308","volume":"14","author":"G Roscia","year":"2013","unstructured":"Roscia G, et al. The development of antimicrobial peptides as new antibacterial drugs. Curr Protein Pept Sci. 2013;14(8):641\u20139.","journal-title":"Curr Protein Pept Sci"},{"issue":"4","key":"1215_CR35","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1096\/fj.09-145474","volume":"24","author":"A Pini","year":"2010","unstructured":"Pini A, et al. A novel tetrabranched antimicrobial peptide that neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo. FASEB J. 2010;24(4):1015\u201322.","journal-title":"FASEB J"},{"issue":"2","key":"1215_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0016690","volume":"6","author":"M Miele","year":"2011","unstructured":"Miele M, Costantini S, Colonna G. Structural and functional similarities between osmotin from Nicotiana tabacum seeds and human adiponectin. PLoS ONE. 2011;6(2):e16690.","journal-title":"PLoS ONE"},{"key":"1215_CR37","doi-asserted-by":"publisher","first-page":"2818","DOI":"10.1007\/s10620-011-1692-0","volume":"56","author":"V Arsenescu","year":"2011","unstructured":"Arsenescu V, et al. Adiponectin and plant-derived mammalian adiponectin homolog exert a protective effect in murine colitis. Dig Dis Sci. 2011;56:2818\u201332.","journal-title":"Dig Dis Sci"},{"key":"1215_CR38","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s11357-010-9173-5","volume":"33","author":"G Qiu","year":"2011","unstructured":"Qiu G, et al. Adiponectin protects rat hippocampal neurons against excitotoxicity. Age. 2011;33:155\u201365.","journal-title":"Age"},{"issue":"2","key":"1215_CR39","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.bbrc.2006.02.186","volume":"343","author":"TW Jung","year":"2006","unstructured":"Jung TW, et al. Adiponectin protects human neuroblastoma SH-SY5Y cells against MPP+-induced cytotoxicity. Biochem Biophys Res Commun. 2006;343(2):564\u201370.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"1215_CR40","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12929-023-00961-z","volume":"30","author":"JS Park","year":"2023","unstructured":"Park JS, et al. Neuroprotective effects of osmotin in Parkinson\u2019s disease-associated pathology via the AdipoR1\/MAPK\/AMPK\/mTOR signaling pathways. J Biomed Sci. 2023;30(1):66.","journal-title":"J Biomed Sci"},{"issue":"1","key":"1215_CR41","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/nprot.2006.342","volume":"2","author":"V Jackson-Lewis","year":"2007","unstructured":"Jackson-Lewis V, Przedborski S. Protocol for the MPTP mouse model of Parkinson\u2019s disease. Nat Protoc. 2007;2(1):141\u201351.","journal-title":"Nat Protoc"},{"issue":"12","key":"1215_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24129942","volume":"24","author":"A Atiq","year":"2023","unstructured":"Atiq A, et al. Vitamin E analog trolox attenuates MPTP-induced Parkinson\u2019s disease in mice, mitigating oxidative stress, neuroinflammation, and motor impairment. Int J Mol Sci. 2023;24(12):9942.","journal-title":"Int J Mol Sci"},{"key":"1215_CR43","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/B978-0-12-405195-9.00008-1","volume-title":"Movement disorders","author":"A Mann","year":"2015","unstructured":"Mann A, Chesselet M-F. Techniques for motor assessment in rodents. In: Movement disorders. Elsevier; 2015. p. 139\u201357."},{"key":"1215_CR44","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.neuropharm.2017.02.022","volume":"117","author":"X Hu","year":"2017","unstructured":"Hu X, et al. Neuroprotective effects of Kukoamine A on neurotoxin-induced Parkinson\u2019s model through apoptosis inhibition and autophagy enhancement. Neuropharmacology. 2017;117:352\u201363.","journal-title":"Neuropharmacology"},{"issue":"12","key":"1215_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11121820","volume":"11","author":"JS Park","year":"2023","unstructured":"Park JS, et al. Immunization effects of a novel \u03b1-Synuclein-based peptide epitope vaccine in Parkinson\u2019s disease-associated pathology. Vaccines. 2023;11(12):1820.","journal-title":"Vaccines"},{"issue":"1","key":"1215_CR46","doi-asserted-by":"publisher","first-page":"e1026","DOI":"10.1038\/cddis.2013.538","volume":"5","author":"SA Shah","year":"2014","unstructured":"Shah SA, et al. Novel osmotin attenuates glutamate-induced synaptic dysfunction and neurodegeneration via the JNK\/PI3K\/Akt pathway in postnatal rat brain. Cell Death Dis. 2014;5(1):e1026\u2013e1026.","journal-title":"Cell Death Dis"},{"issue":"11","key":"1215_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11112107","volume":"11","author":"HJ Lee","year":"2022","unstructured":"Lee HJ, et al. O-cyclic phytosphingosine-1-phosphate protects against motor dysfunctions and glial cell mediated neuroinflammation in the parkinson\u2019s disease mouse models. Antioxidants. 2022;11(11):2107.","journal-title":"Antioxidants"},{"issue":"17","key":"1215_CR48","doi-asserted-by":"publisher","first-page":"9583","DOI":"10.3390\/ijms22179583","volume":"22","author":"S Ahmad","year":"2021","unstructured":"Ahmad S, et al. Deciphering the potential neuroprotective effects of luteolin against A\u03b21\u201342-induced alzheimer\u2019s disease. Int J Mol Sci. 2021;22(17):9583.","journal-title":"Int J Mol Sci"},{"key":"1215_CR49","doi-asserted-by":"publisher","first-page":"5127","DOI":"10.1007\/s12035-021-02460-4","volume":"58","author":"A Khan","year":"2021","unstructured":"Khan A, et al. Antioxidative and anti-inflammatory effects of kojic acid in A\u03b2-induced mouse model of Alzheimer\u2019s disease. Mol Neurobiol. 2021;58:5127\u201340.","journal-title":"Mol Neurobiol"},{"issue":"2","key":"1215_CR50","doi-asserted-by":"publisher","first-page":"178","DOI":"10.4062\/biomolther.2018.234","volume":"27","author":"J-S Park","year":"2019","unstructured":"Park J-S, et al. Neuroprotective effect of \u03b2-lapachone in MPTP-induced Parkinson\u2019s disease mouse model: involvement of astroglial p-AMPK\/Nrf2\/HO-1 signaling pathways. Biomol Therap. 2019;27(2):178.","journal-title":"Biomol Therap"},{"issue":"1","key":"1215_CR51","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s40478-014-0176-9","volume":"2","author":"RM Gir\u00e1ldez-P\u00e9rez","year":"2014","unstructured":"Gir\u00e1ldez-P\u00e9rez RM, et al. Models of \u03b1-synuclein aggregation in Parkinson\u2019s disease. Acta Neuropathol Commun. 2014;2(1):176.","journal-title":"Acta Neuropathol Commun"},{"issue":"7","key":"1215_CR52","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1021\/acschemneuro.6b00064","volume":"7","author":"MF Salvatore","year":"2016","unstructured":"Salvatore MF, Calipari ES, Jones SR. Regulation of tyrosine hydroxylase expression and phosphorylation in dopamine transporter-deficient mice. ACS Chem Neurosci. 2016;7(7):941\u201351.","journal-title":"ACS Chem Neurosci"},{"issue":"1\u20132","key":"1215_CR53","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jneuroim.2008.08.003","volume":"204","author":"Y Yasuda","year":"2008","unstructured":"Yasuda Y, et al. The effects of MPTP on the activation of microglia\/astrocytes and cytokine\/chemokine levels in different mice strains. J Neuroimmunol. 2008;204(1\u20132):43\u201351.","journal-title":"J Neuroimmunol"},{"issue":"3","key":"1215_CR54","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1002\/glia.24295","volume":"71","author":"L Basurco","year":"2023","unstructured":"Basurco L, et al. Microglia and astrocyte activation is region-dependent in the \u03b1-synuclein mouse model of Parkinson\u2019s disease. Glia. 2023;71(3):571\u201387.","journal-title":"Glia"},{"issue":"2","key":"1215_CR55","doi-asserted-by":"publisher","DOI":"10.1042\/AN20120066","volume":"5","author":"V Sanchez-Guajardo","year":"2013","unstructured":"Sanchez-Guajardo V, et al. Neuroimmunological processes in Parkinson\u2019s disease and their relation to \u03b1-synuclein: microglia as the referee between neuronal processes and peripheral immunity. ASN Neuro. 2013;5(2):AN20120066.","journal-title":"ASN Neuro"},{"key":"1215_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fvets.2021.660022","volume":"8","author":"GS Boos","year":"2021","unstructured":"Boos GS, et al. Glial fibrillary acidic protein and ionized calcium-binding adapter molecule 1 immunostaining score for the central nervous system of horses with non-suppurative encephalitis and encephalopathies. Front Vet Sci. 2021;8:660022.","journal-title":"Front Vet Sci"},{"key":"1215_CR57","doi-asserted-by":"publisher","first-page":"3221","DOI":"10.1007\/s00018-016-2223-0","volume":"73","author":"A Loboda","year":"2016","unstructured":"Loboda A, et al. Role of Nrf2\/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism. Cell Mol Life Sci. 2016;73:3221\u201347.","journal-title":"Cell Mol Life Sci"},{"issue":"2","key":"1215_CR58","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s11011-020-00641-z","volume":"36","author":"AB Enogieru","year":"2021","unstructured":"Enogieru AB, et al. Regulation of AKT\/AMPK signaling, autophagy and mitigation of apoptosis in Rutin-pretreated SH-SY5Y cells exposed to MPP+. Metab Brain Dis. 2021;36(2):315\u201326.","journal-title":"Metab Brain Dis"},{"key":"1215_CR59","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.926634","volume":"14","author":"A Lauritano","year":"2022","unstructured":"Lauritano A, et al. The endocannabinoidome mediator N-oleoylglycine is a novel protective agent against 1-methyl-4-phenyl-pyridinium-induced neurotoxicity. Front Aging Neurosci. 2022;14:926634.","journal-title":"Front Aging Neurosci"},{"issue":"1-2","key":"1215_CR60","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/S0006-8993(02)02422-8","volume":"935","author":"C G\u00f3mez-Santos","year":"2002","unstructured":"G\u00f3mez-Santos C, et al. MPP+ increases \u03b1-synuclein expression and ERK\/MAP-kinase phosphorylation in human neuroblastoma SH-SY5Y cells. Brain Res. 2002;935(1\u20132):32\u20139.","journal-title":"Brain Res"},{"issue":"11","key":"1215_CR61","doi-asserted-by":"publisher","first-page":"3959","DOI":"10.3390\/ijms21113959","volume":"21","author":"A Wilkaniec","year":"2020","unstructured":"Wilkaniec A, et al. P2X7 receptor is involved in mitochondrial dysfunction induced by extracellular alpha synuclein in neuroblastoma SH-SY5Y cells. Int J Mol Sci. 2020;21(11):3959.","journal-title":"Int J Mol Sci"},{"issue":"5456","key":"1215_CR62","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1126\/science.287.5456.1265","volume":"287","author":"E Masliah","year":"2000","unstructured":"Masliah E, et al. Dopaminergic loss and inclusion body formation in \u03b1-synuclein mice: implications for neurodegenerative disorders. Science. 2000;287(5456):1265\u20139.","journal-title":"Science"},{"key":"1215_CR63","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s10571-007-9141-5","volume":"27","author":"S Zach","year":"2007","unstructured":"Zach S, et al. Predominant neuritic pathology induced by viral overexpression of \u03b1-synuclein in cell culture. Cell Mol Neurobiol. 2007;27:505\u201315.","journal-title":"Cell Mol Neurobiol"},{"issue":"1","key":"1215_CR64","doi-asserted-by":"publisher","first-page":"6237","DOI":"10.1038\/s41467-021-26519-x","volume":"12","author":"S Bido","year":"2021","unstructured":"Bido S, et al. Microglia-specific overexpression of \u03b1-synuclein leads to severe dopaminergic neurodegeneration by phagocytic exhaustion and oxidative toxicity. Nat Commun. 2021;12(1):6237.","journal-title":"Nat Commun"},{"key":"1215_CR65","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S235562","author":"S Hu","year":"2020","unstructured":"Hu S, et al. Phosphorylation of tau and \u03b1-synuclein induced neurodegeneration in MPTP mouse model of Parkinson\u2019s disease. Neuropsychiatri Dis Treat. 2020. https:\/\/doi.org\/10.2147\/NDT.S235562.","journal-title":"Neuropsychiatri Dis Treat"},{"key":"1215_CR66","doi-asserted-by":"crossref","unstructured":"Tabrez S, et al., A synopsis on the role of tyrosine hydroxylase in Parkinson\u2019s disease. CNS Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders). 2012. 11 4 395\u2013409.","DOI":"10.2174\/187152712800792785"},{"issue":"1","key":"1215_CR67","volume":"2011","author":"TN Taylor","year":"2011","unstructured":"Taylor TN, Caudle WM, Miller GW. VMAT2\u2010deficient mice display nigral and extranigral pathology and motor and nonmotor symptoms of Parkinson\u2032 s disease. Parkinson\u2019s Dis. 2011;2011(1):124165.","journal-title":"Parkinson\u2019s Dis"},{"issue":"1","key":"1215_CR68","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/0169-328X(95)00278-Z","volume":"36","author":"K Harrington","year":"1996","unstructured":"Harrington K, et al. Dopamine transporter (Dat) and synaptic vesicle amine transporter (VMAT2) gene expression in the substantia nigra of control and Parkinson\u2019s disease. Mol Brain Res. 1996;36(1):157\u201362.","journal-title":"Mol Brain Res"},{"issue":"4","key":"1215_CR69","doi-asserted-by":"publisher","first-page":"350","DOI":"10.2174\/187152712800792901","volume":"11","author":"Y Zhu","year":"2012","unstructured":"Zhu Y, Zhang J, Zeng Y. Overview of tyrosine hydroxylase in Parkinson\u2019s disease. CNS Neurol Disord. 2012;11(4):350\u20138.","journal-title":"CNS Neurol Disord"},{"key":"1215_CR70","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2024.1347987","volume":"16","author":"A Adamu","year":"2024","unstructured":"Adamu A, et al. The role of neuroinflammation in neurodegenerative diseases: current understanding and future therapeutic targets. Front Aging Neurosci. 2024;16:1347987.","journal-title":"Front Aging Neurosci"},{"issue":"12","key":"1215_CR71","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24129903","volume":"24","author":"M G\u0105ssowska-Dobrowolska","year":"2023","unstructured":"G\u0105ssowska-Dobrowolska M, et al. Microglia and astroglia\u2014the potential role in neuroinflammation induced by pre-and neonatal exposure to lead (Pb). Int J Mol Sci. 2023;24(12):9903.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1215_CR72","volume":"2011","author":"D Litteljohn","year":"2011","unstructured":"Litteljohn D, et al. Inflammatory mechanisms of neurodegeneration in toxin-based models of Parkinson\u2032s disease. Parkinson\u2019s Dis. 2011;2011(1):713517.","journal-title":"Parkinson\u2019s Dis"},{"key":"1215_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2024.103256","volume":"147","author":"Y-H Choe","year":"2024","unstructured":"Choe Y-H, et al. The autoimmune response induced by \u03b1-synuclein peptides drives neuronal cell death and glial cell activation. J Autoimmun. 2024;147:103256.","journal-title":"J Autoimmun"},{"issue":"12","key":"1215_CR74","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1097\/NEN.0b013e31818e5e99","volume":"67","author":"S Theodore","year":"2008","unstructured":"Theodore S, et al. Targeted overexpression of human \u03b1-synuclein triggers microglial activation and an adaptive immune response in a mouse model of Parkinson disease. J Neuropathol Exp Neurol. 2008;67(12):1149\u201358.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"6","key":"1215_CR75","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.tins.2017.04.001","volume":"40","author":"HD Booth","year":"2017","unstructured":"Booth HD, Hirst WD, Wade-Martins R. The role of astrocyte dysfunction in Parkinson\u2019s disease pathogenesis. Trends Neurosci. 2017;40(6):358\u201370.","journal-title":"Trends Neurosci"},{"key":"1215_CR76","doi-asserted-by":"publisher","DOI":"10.3390\/cells10061348","author":"R Kono","year":"2021","unstructured":"Kono R, Ikegaya Y, Koyama R. Phagocytic glial cells in brain homeostasis. Cells. 2021. https:\/\/doi.org\/10.3390\/cells10061348.","journal-title":"Cells"},{"issue":"1","key":"1215_CR77","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.neuron.2015.11.013","volume":"89","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, et al. Purification and characterization of progenitor and mature human astrocytes reveals transcriptional and functional differences with mouse. Neuron. 2016;89(1):37\u201353.","journal-title":"Neuron"},{"key":"1215_CR78","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2022.903469","volume":"16","author":"X Zhang","year":"2022","unstructured":"Zhang X, et al. The mechanism and function of glia in Parkinson\u2019s disease. Front Cell Neurosci. 2022;16:903469.","journal-title":"Front Cell Neurosci"},{"issue":"24","key":"1215_CR79","doi-asserted-by":"publisher","first-page":"5171","DOI":"10.1007\/s00018-020-03584-x","volume":"77","author":"AV Domingues","year":"2020","unstructured":"Domingues AV, et al. Glial cells in Parkinson\u00b4s disease: protective or deleterious? Cell Mol Life Sci. 2020;77(24):5171\u201388.","journal-title":"Cell Mol Life Sci"},{"issue":"8","key":"1215_CR80","doi-asserted-by":"publisher","first-page":"647","DOI":"10.3390\/antiox9080647","volume":"9","author":"A Picca","year":"2020","unstructured":"Picca A, et al. Mitochondrial dysfunction, oxidative stress, and neuroinflammation: intertwined roads to neurodegeneration. Antioxidants. 2020;9(8):647.","journal-title":"Antioxidants"},{"key":"1215_CR81","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.757161","volume":"12","author":"Y Wang","year":"2021","unstructured":"Wang Y, et al. Pharmacological modulation of Nrf2\/HO-1 signaling pathway as a therapeutic target of Parkinson\u2019s disease. Front Pharmacol. 2021;12:757161.","journal-title":"Front Pharmacol"},{"issue":"2","key":"1215_CR82","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.tifs.2011.08.010","volume":"23","author":"D Agyei","year":"2012","unstructured":"Agyei D, Danquah MK. Rethinking food-derived bioactive peptides for antimicrobial and immunomodulatory activities. Trends Food Sci Technol. 2012;23(2):62\u20139.","journal-title":"Trends Food Sci Technol"},{"key":"1215_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/j.jff.2023.105839","volume":"110","author":"Y Qi","year":"2023","unstructured":"Qi Y, et al. Anti-inflammatory effect of walnut-derived peptide via the activation of Nrf2\/Keap1 pathway against oxidative stress. J Funct Foods. 2023;110:105839.","journal-title":"J Funct Foods"},{"key":"1215_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.jff.2020.103944","volume":"69","author":"J Wang","year":"2020","unstructured":"Wang J, et al. Anti-diabetic effect by walnut (Juglans mandshurica Maxim.)-derived peptide LPLLR through inhibiting \u03b1-glucosidase and \u03b1-amylase, and alleviating insulin resistance of hepatic HepG2 cells. J Funct Foods. 2020;69:103944.","journal-title":"J Funct Foods"},{"issue":"19","key":"1215_CR85","doi-asserted-by":"publisher","first-page":"5536","DOI":"10.1021\/acs.jafc.1c01908","volume":"69","author":"M Li","year":"2021","unstructured":"Li M, et al. Potential mechanisms mediating the protective effects of Tricholoma matsutake-derived peptides in mitigating DSS-induced colitis. J Agric Food Chem. 2021;69(19):5536\u201346.","journal-title":"J Agric Food Chem"},{"key":"1215_CR86","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.tifs.2022.11.004","volume":"129","author":"L Xiong","year":"2022","unstructured":"Xiong L, et al. Potential of food protein-derived peptides for the improvement of osteoarthritis. Trends Food Sci Technol. 2022;129:544\u201357.","journal-title":"Trends Food Sci Technol"}],"container-title":["Journal of Biomedical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12929-026-01215-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12929-026-01215-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12929-026-01215-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T06:02:14Z","timestamp":1769407334000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12929-026-01215-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,26]]},"references-count":86,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1215"],"URL":"https:\/\/doi.org\/10.1186\/s12929-026-01215-4","relation":{},"ISSN":["1423-0127"],"issn-type":[{"value":"1423-0127","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,26]]},"assertion":[{"value":"16 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal study was approved by the Animal Ethics Committee of the Division of Applied Life Sciences, Department of Biology, Gyeongsang National University, South Korea. The study was conducted in accordance with the local legislation and institutional requirements.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13"}}